Dollar General (DG) Declines More Than Market: Some Information for Investors

Dollar General shares fell 1.1% to $103.15, underperforming the broader market, as investors await the retailer’s Dec. 4, 2025 earnings release; analysts expect Q4 EPS of $0.95 (+6.7% year‑over‑year) on revenue of $10.62 billion (+4.3%) and full‑year estimates of $6.13 EPS and $42.5 billion in revenue. Zacks notes only a modest 0.02% upward EPS revision over the past 30 days and assigns DG a Zacks Rank of #2 (Buy); valuation metrics show a forward P/E of 17 versus the industry average of 25.9 and a PEG of 2.19 (industry PEG 2.63), implying the stock trades at a relative discount despite moderate growth expectations. Investors should watch for any further estimate revisions around the report, which Zacks says historically correlate with near‑term stock performance.

Analysis

Dollar General shares closed at $103.15, down 1.1% on the most recent trading day, underperforming the S&P 500 (down 0.92%) while the Dow and Nasdaq fell 1.18% and 0.84%, respectively; prior to the session the stock had lost 1.36% while the Retail‑Wholesale sector gained 0.48% and the S&P gained 1.48%, signaling recent relative weakness. Investors are focused on the upcoming earnings release scheduled for December 4, 2025, which is positioned as the immediate catalyst.

Zacks consensus calls for Q4 EPS of $0.95 (up 6.74% year‑over‑year) and revenue of $10.62 billion (up 4.25%), with full‑year estimates of $6.13 EPS (+3.55%) and $42.5 billion revenue (+4.66%); the consensus EPS projection has moved only +0.02% in the past 30 days, and DG carries a Zacks Rank of #2 (Buy), indicating constructive but largely stable analyst sentiment. Zacks highlights that estimate revisions tend to correlate with near‑term stock performance, so revision momentum (or lack thereof) is a key signal ahead of the print.

Valuation compares favorably to peers: forward P/E is 17 versus the industry average of 25.89, and DG’s PEG of 2.19 is below the industry PEG of 2.63, implying a relative discount on growth‑adjusted terms. Given the mild positive sentiment and low recent revision activity, the stock offers upside if the December report beats or guidance improves, but limited estimate momentum and recent underperformance increase the risk of muted near‑term returns.

Key Decisions for Investors

• Consider maintaining or modestly adding to positions ahead of the December 4 earnings with disciplined position sizing because the stock trades at a forward P/E discount (17) and has a Zacks #2 rating, but avoid large incremental exposure given limited revision momentum
• Prioritize monitoring the December 4 print for EPS/revenue beats and management guidance and act on any material upward analyst estimate revisions, since Zacks data shows those revisions are a primary near‑term catalyst
• Avoid initiating large new positions immediately before the report or implement protective hedges because recent relative underperformance and only a 0.02% EPS revision in 30 days imply elevated event risk and limited visible catalysts